Management of Kaposi's sarcoma. Chemotherapy II.
D001761:Bleomycin / Q000627:therapeutic use; D002330:Carmustine / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D003606:Dacarbazine / Q000627:therapeutic use; D003609:Dactinomycin / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D006801:Humans; D011929:Razoxane / Q000627:therapeutic use; D012514:Sarcoma, Kaposi / Q000188:drug therapy*; D014454:Uganda; D014750:Vincristine / Q000627:therapeutic use
D001761:Bleomycin; D003609:Dactinomycin; D011929:Razoxane; D014750:Vincristine; D003606:Dacarbazine; D002330:Carmustine